Evidence map›Paper›PMID 28918489›Full record

ArticleRheumatology international2017

Yersinia enterocolitica biotype 1A: a possible new trigger of reactive arthritis.

Riitta Tuompo, Timo Hannu, Elisa Huovinen, Leila Sihvonen, Anja Siitonen, Marjatta Leirisalo-Repo

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Yersiniosis in New Zealand.Pathogens (Basel, Switzerland) · 2021
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Riitta TuompoRheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. riitta.tuompo@hus.fi.
Timo HannuDepartment of Public Health, Hjelt Institute, University of Helsinki, Helsinki, Finland.
Elisa HuovinenEpidemiologic Surveillance and Response Unit, National Institute for Health and Welfare (THL), Helsinki, Finland.
Leila SihvonenBacteriology Unit, National Institute for Health and Welfare (THL), Helsinki, Finland.
Anja SiitonenBacteriology Unit, National Institute for Health and Welfare (THL), Helsinki, Finland.
Marjatta Leirisalo-RepoRheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Finnish Institute for Health and Welfare · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Yersinia enterocolitica (YE) biotype 1A is generally considered non-pathogenic, and the role of it in causing reactive musculoskeletal complications is unclear. We evaluated the capability of YE biotype 1A to induce reactive arthritis (ReA) and other reactive musculoskeletal symptoms. Analysis of self-reported musculoskeletal symptoms was supplemented with a telephone interview (with a permission to acquire copies of patient files from a local physician or hospital) and/or clinical examination of subjects with recent musculoskeletal symptoms after a positive stool culture for YE. The diagnoses of ReA and reactive tendinitis and enthesitis (ReTe) were defined as "definite" when based on clinical examination and/or on interview by phone and "probable" when based solely on the questionnaire. Of 120 subjects, who reported musculoskeletal symptoms, 100 were included in the final analysis. Among these 100 patients, 68% had YE biotype 1A, 16% YE bio/serotype 4, and 1% biotype 2 infection; the remaining 15% had different YE-like strains or a non-biotypable strain. Of the 21 patients with ReA and of the 14 patients with ReTe, the diagnosis was definite in 9 and 7 patients and probable in 12 and 7 patients, respectively. The clinical picture of ReA caused by YE biotype 1A was similar with other bio/serotypes of YE. The definite ReA due to YE biotype 1A occurred in middle-aged adults (5 men, 4 women) with the most frequently affected joints being the knees and ankles. We suggest that YE biotype 1A should be taken into account as a new trigger of ReA.

Indexed as

AdultAgedAged, 80 and overArthritis, ReactiveBacterial Typing TechniquesCase-Control StudiesFemaleHumansMaleMiddle AgedProhibitinsYersinia enterocoliticaYoung AdultProhibitinsInfection arthritisReactive arthritisSpondyloarthritisYersinia enterocolitica

Identifiers

PMID28918489
OpenAlexW2756403709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.